Elucidation for coordination features of hydrazide ligand under influence of variable anions in bivalent transition metal salts; green synthesis, biological activity confirmed by in-silico approaches

Green approach to synthesize novel thiosemicarbazide complexes, characterization; DNA-methyl green assay and in-silico studies against DNA polymerase

A thiosemicarbazide derivative as (E)-4-ethyl-1-(1-(naphthalen-1-yl) ethylidene) thiosemicarbazide (HAN) was synthesized then characterized to prepare [Co(HAN)Cl2·(H2O)2], [Ni(HAN)Cl2·(H2O)2]. H2O, and [Cd(HAN)Cl2] complexes. According to spectral and analytical data we could confirm the neutral bidentate mode of bonding via (C]S) and (C]N) groups to form 1:1 M ratio within the three complexes. The octahedral geometry was suggested for Co(II) and Ni(II) complexes according to electronic transitions assigned to 4T1g → 4T1g(P)(ʋ2) and 4T1g → 4A2g(F)(ʋ3) and 3A2g → 3T1g(P,υ3) and 3A2g → 3T1g(F,υ2), respectively. The values of nephelauetic ratio (β) in the ligand field parameters detect the ionic nature of new M-L bonds. The molecular ion peaks appeared in the mass spectra of two selected complexes confirming their molecular formulae. The conductometric study was performed for Cd(II) ion solution during variable additions of HAN to calculate association and formation constant of Cd(II)-HAN complex. DFT/B3LYP method was used to optimize the structures of the compounds and confirm the binding mode of the ligand. The distribution of C(5) = N(17) and C(13) = S(19) groups asserts their priority in coordination. Hirshfeld crystal properties were obtained via normalized contact distance (dnorm) and shape index in which the nitrogen atoms act as the best contact points in crystal packing. The biological screening was carried out against microbial strains as well as methyl green/DNA test. In vitro, the superiority of the ligand was clearly recorded in its biological effectiveness. In silico methods were implemented to confirm the activity of the ligand and to recognize the interaction features. The bioavailability, pharmacokinetics and drug-likeness were evaluated via Swiss-link. The data detect the ability of the ligand to penetrate barrier of brain (BBB) but not absorbed in gastrointestinal tract. Pharmit link and molecular docking were utilized to investigate the interaction of HAN with 1bna, 425d and 2k4l proteins. The best intercalation with protein pockets was observed with 2k4l protein, and searching the MolPort library detects a drug analog of MolPort-002-894-701. Finally, the results suggest the biological efficiency of the ligand, which may be asserted by specialists through intensive in-vivo studies.

Synthesis and Characterization of New Mixed-Ligand Complexes; Density Functional Theory, Hirshfeld, and In Silico Assays Strengthen the Bioactivity Performed In Vitro

N'-Acetyl-2-cyanoacetohydrazide (H₂L¹) and 2-cyano-N-(6-ethoxybenzo thiazol-2-yl) acetamide (HL²) ligands were used to synthesize [Cr(OAc)(H₂L¹)(HL²)]·2(OAc) and [Mn(H₂L¹)(HL²)]·Cl₂·2H₂O as mixed ligand complexes. All new compounds were analyzed by analytical, spectral, and computational techniques to elucidate their chemical formulae. The bidentate nature was suggested for each coordinating ligand via ON donors. The electronic transitions recorded are attributing to ⁴A₂g(F) → ⁴T₂g(F)(υ₂) and ⁴A₂g(F) → ⁴T₁g(F)(υ₃) types in the octahedral Cr(III) complex, while ⁶A₁ → ⁴T₂(G) and ⁶A₁ → ⁴T₁(G) transitions are attributing to the tetrahedral Mn(II) complex. These complexes were optimized by the density functional theory method to verify the bonding mode which was suggested via N(3), O(8), N(9), and N(10) donors from the mixed-ligands. Hirshfeld crystal models were demonstrated for the two ligands to indicate the distance between the functional groups within the two ligands and supporting the exclusion of self-interaction in between. Finally, the biological activity of the two mixed ligand complexes was tested by in silico ways as well as in vitro ways for confirmation. Three advanced programs were applied to measure the magnitude of biological efficiency of the two complexes toward kinase enzyme (3nzs) and breast cancer proliferation (3hy3). All in silico data suggest the superiority of the Mn(II) complex. Moreover, the in vitro assays for the two complexes that measure their antioxidant and cytotoxic activity support the distinguished activity of the Mn(II) complex.